Accolade raised $220 million and received a market cap of $1.1 billion. This suggests a possible upside of 8.8% from the stock's current price. When running Accolade stock analysis, check to measure Accolade's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. Castlight has struggled since it went public in 2014, with its stock … Two things: Technology + Service. Accolade paid $230 million in cash and $130 million in Accolade stock for 2nd.MD, which, like PlushCare, had $35 million in revenue last year. Accolade General Information Description. Shares of Accolade ( ACCD) jumped in their first day of trading as the Seattle health benefits company went public at a price above its estimate. Accolade plans to acquire virtual primary care provider PlushCare in a $450M stock and cash deal PlushCare is a virtual primary care service and Accolade plans to … Health tech company Accolade goes public at $1.2B valuation in Seattle’s first IPO of 2020. Accolade, a digital health company with a personalized health benefits platform, announced it has signed a definitive agreement to acquire PlushCare, a provider of virtual primary care and mental health treatment. Barnes attributed the heightened interest in the company's stock to role Accolade plays helping people overcome common frustrations when seeking, receiving and paying for health care. It generates revenue by providing personalized health guidance solutions to members. It specializes in healthcare process improvement, healthcare savings, employee engagement, and personalized advocacy. $200bn+ combined total addressable market materially expands opportunity to reinvent healthcare with a focus on improving health outcomes and managing rising costs. SEATTLE, Sept. 17, 2020 /PRNewswire/ -- Accolade (NASDAQ: ACCD), a personalized health and benefits solution for employers, health plans … Jun 10, 2021 7:46AM EDT A ccolade, Inc. (ACCD) has completed the acquisition of PlushCare, a provider of virtual primary care and mental health treatment in a … According to Accolade’s June 24th S-1/A, the company expects a $19 to $21 per-share IPO price range. June 9, 2021. All employment is decided on the basis of qualifications, merit, and business need. Accolade estimates its total addressable market for its current solutions to be approximately $24 … On average, they expect Accolade's stock price to reach $54.92 in the next year. Accolade Completes Acquisition of PlushCare. Accolade has a handful of competitors in the space, including Castlight Health and Welltok. Accolade’s team of compassionate, trusted professionals is supported by breakthrough science and technologies to guide people through the healthcare system in a deeply personalized manner. Accolade Stock. With an integrated app and integrated capabilities of many players in the entire system the goal is to deliver on personalized recommendations, both in at a cost and quality efficient manner. After seeing the success of many other healthcare companies during the pandemic, Accolade priced its stock on July 1, 2020. Accolade solutions are designed with next-generation technology that generates millions of data-driven insights from hundreds of sources to help each person live their healthiest life. The offering of … - ACCD already has a partner ecosystem with various payers (Cigna, united, etc.) The company aims to create a single place to turn to when looking for health, healthcare and benefit needs. The company has developed an … 12 brokers have issued twelve-month price objectives for Accolade's stock. ACCD: Get the latest Accolade stock price and detailed information including ACCD news, historical charts and realtime prices. Headquarters Plymouth Meeting, Pennsylvania. Accolade Inc offers technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits. Clients of Accolade are actually employers which aim to look after workers and includ… Apr 26th, 2021. Accolade helps millions of people and their employers navigate the complexities of the healthcare system with empathy, expertise and through exceptional service while supporting them in lowering the cost of care and improving health outcomes. October 14, 2020 16:03 ET | Source: Accolade, Inc. Fiscal second quarter 2021 revenue of $36.8 million, a … Accolade, listed under the ACCD ticker symbol, raised $220 million through an initial public offering of 10 million shares at $22 each — set above analysts’ estimated range of $19 to $21. Under the terms of the agreement, the purchase price of up to $450 million will consist of $40 million in cash, $340 million in Accolade common stock, and up to an additional $70 million of value payable upon the achievement of defined revenue milestones following the closing. Accolade, which provides a platform that helps employees manage their healthcare benefits, filed on Friday with the SEC to raise up to $100 million in … Seattle-based healthtech software company Accolade went public on Thursday morning. Accolade agrees to buy medical-expert company for $460 million Jan. 14, 2021 at 5:23 p.m. Accolade to begin offering virtual primary care and mental health consultations directly to members. Accolade is proud to be an Equal Opportunity and Affirmative Action employer. Last month, Accolade completed buying 2nd.MD, a Houston company that extended Accolade’s health-care navigation services into second opinions by specialists online. Accolade Announces Results for Fiscal Second Quarter 2021. Founded 2007. Accolade consistently receives consumer satisfaction ratings over 90 percent. Accolade. We commit to having an inclusive environment and anti-harassment culture for all employees, and to creating a positive impact on our colleagues, customers, and in the community. The company’s original price range was $19 to $21. Health benefits platform Accolade made its initial public offering Thursday morning, pricing its stock at $22/share, above the expected range of $19 to $21, and raising $220 million at a valuation of $1. But let’s look at the business model in example: Accolade currently only has 60 customers, they have some big ones (Comcast, Intuit, American Airlines) - AA sets up with Accolade to manage their employee benefits. Fiscal Year End Dec 31, 2012. Accolade blends technology-enabled health and benefits solutions, specialized support from Accolade Health Assistants® and Clinicians and access to expert medical opinion services for high-cost treatment decisions. SEATTLE, July 7, 2020 /PRNewswire/ -- Accolade, Inc. (NASDAQ: ACCD), which provides personalized, technology-enabled solutions that … Accolade is an on-demand healthcare concierge for employers, health plans and health systems. Accolade, a start-up that helps workers navigate their health benefits and dealings with insurance companies, has hired banks including Goldman Sachs and Morgan Stanley to … Accolade’s S-1/A. Accolade, a health care service for employees to manage benefits, is buying virtual primary care startup PlushCare for up to $450M, in a cash and stock deal — The news: Seattle-based health benefits platform Accolade will pay up to $450 million to acquire PlushCare, a Bay Area-based startup that offers virtual primary care. Their forecasts range from $39.00 to $62.00. Accolade, a health care technology company that helps employees navigate their medical plans, is buying telemedicine start-up 2nd.MD to … Shares in Accolade Inc. rose nearly 10% Friday on news that the company agreed to pay $360 million for 2nd.MD, a Houston company that will extend Accolade’s health-care … Accolade (ACCD) has filed to raise $175 million from the sale of its common stock in an IPO, according to an amended registration statement. ET by Claudia Assis Accolade started at buy with $48 stock price target at Stifel Nicolaus We have many different tools that can be utilized to determine how healthy Accolade is … Health care technology company Accolade to offer 8.75 million shares in IPO, priced at $19 to $21 each Jun. 24, 2020 at 6:40 a.m. ET by Ciara Linnane No Headlines Available Industry Health Care Equipment & Svcs. View Accolade, Inc. ACCD investment & stock information. Get the latest Accolade, Inc. ACCD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Accolade has a mission to empower people through expertise, empathy and technology, making the best decisions for health and well-being. Accolade, Inc. engages in the provision of personalized health and benefits solutions. Its products include Accolade Total Benefits, which is designed for employers with low employee adoption of healthcare and benefits programs; Accolade Total Care, which focuses on influencing the actual interactions between employees and providers, and are also interested in care management services; … View the latest Accolade Inc. (ACCD) stock price, news, historical charts, analyst ratings and financial information from WSJ. Accolade, Inc. is an emerging growth company, which engages in the provision of personalized, technology-enabled solutions through a technology platform. It offers Accolade Total Benefits and Accolade Total Care. Accolade Total Benefits focuses on member benefits engagement... About Accolade Stock Accolade is a health, wellness, and fitness company that features personalized health and benefits solutions that help to improve the experience, outcomes, and cost of healthcare for employers. The company announced its initial private offering of over 10 million shares of stock at a price of $22 per share, with the shares trading under the ticker symbol ACCD. However, on July 2, Accolade stock began trading at $22 a share. (Via Nasdaq webcast) Health benefits platform Accolade made its initial public offering Thursday morning, pricing its stock at $22/share, above the … Accolade, Inc. (ACCD) has completed the acquisition of PlushCare, a provider of virtual primary care and mental health treatment in a cash and stock deal valuing $450 million. SEATTLE, June 01, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in … Health benefits tech company Accolade sees revenue rise 24% to $36.8M, but stock dips Previous Story ManipulaTHOR training software from AI2 gives virtual robots a hand — and an arm Founders Michael Cline, Tom Spann. The proposed deal sent Accolade's stock up almost 10% Friday, closing at $52.35 per share. Press Releases.

Stereopsis Psychology, Warframe Deimos Standing, Dodge Demon 2021 Top Speed, Does Morality Depend On Religion Essay, Coppin State University Majors,